Radiation Dosimetry for Adults
| Radiopharmaceuticals | Administered activity (MBq [mCi]) | Organ Receiving largest radiation dose (mGy/MBq [rad/mCi]) | Effective dose (mSv/MBq [rem/mCi]) |
| 18F-FDG | 370–740 intravenously (10–20) | 0.15 bladder wall (0.56) | 0.019 (0.07) |
| Na123I iodide (0% thyroid uptake) | 74–148 by mouth (2–4) | 0.097 bladder wall (0.36) | 0.010 (0.039) |
| Na131I iodide (0% thyroid uptake) | 37–148 by mouth (1–4) | 0.66 bladder wall (2.4) | 0.058 (0.21) |
https://www.doseinfo-radar.com. Accessed August 18, 2020.
International Commission on Radiological Protection. Radiation Doses to Patients from Radiopharmaceuticals. New York, NY: Elsevier. 2008.
Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med 2006;47:885–895.